LYVE1 and B-cell chronic lymphocytic leukemia: Because the high-dose CLL treatment (25 μL) caused more severe damage to MLVs than the low-dose treatment (5 μL), lymphatic endothelial cells, which express LYVE-1, may have phagocytosed CLL, leading to apoptosis.